Press release
Kidney Fibrosis Treatment Market to Incur Rapid Extension During 2010-2020
Kidney fibrosis may be caused due to disease in kidney. It may be any stage from chronic kidney disease (CKD) to end-stage renal disease (ESRD). In this condition, kidneys stop working and gradually require transplantation. Various medications that are available in the market for treatment of kidney fibrosis are Renin inhibitors, Vasopeptidase inhibitors, Angiotensin II receptor blockers (ARBs), Angiotensin-converting enzyme (ACE) inhibitors and Pirfenidones. Increasing prevalence of kidney diseases and no other alternative treatment available is driving the market for kidney fibrosis treatment.
Request Report for TOC @ https://www.persistencemarketresearch.com/toc/3102
North America, followed by the Europe, dominates the global market for kidney fibrosis due to large number of aging population and better healthcare facilities available in the region. In addition, there is high prevalence of kidney diseases in the region. According to The Centers for Disease Control and Prevention (CDC), a public health institute in 2014, in the U.S., it is estimated that more than 20 million people are suffering from chronic kidney disease.
Asia is expected to show high growth rate in the next few years in global kidney fibrosis treatment market. China and India are expected to be the fastest kidney fibrosis market in Asia region. Some of the key driving forces for kidney fibrosis market in emerging countries are increasing R&D investment, large pool of patients, rising government funding and growing level of awareness.
Request To Sample of Report @ https://www.persistencemarketresearch.com/samples/3102
Diseases such as obesity accelerate the incidence of kidney fibrosis. In addition, habits such smoking also adds to increment in incidence of kidney fibrosis. Increasing patient pool, rising awareness about treatment of kidney diseases and government funding are some of the key factors driving the kidney fibrosis market. In addition, introduction of safer and effective therapeutics for the treatment of kidney fibrosis is driving the market. However, high cost involved and no success for all the cases is restraining the kidney fibrosis market.
Introduction of the concept of personalized medicines, mono-therapeutic approaches or combination of therapies are expected to offer good opportunities for kidney fibrosis market. In addition, introduction statins for, which are related to lowering of lipid content, thus expected to be an efficient treatment for kidney scarring. Growing demographics and economies in the developing countries such as India and China in Asia and other countries in South East Asia, Latin America and Middle East are expected to offer high growth in kidney fibrosis treatment market.
One of the major trends that have been observed in kidney fibrosis treatment market includes various pharmaceutical and biotechnology companies involved in R&D of some novel medications for the treatment of kidney fibrosis. Some of the key companies dealing in kidney fibrosis treatment market are F. Hoffmann-La Roche Ltd., Pfizer, Inc, La Jolla Pharmaceutical Company, Merck & Co., InterMune, Inc. and Galectin Therapeutics, Inc. Other companies dealing the kidney fibrosis treatment market which have significant presence are Genzyme Corporation, ProMetic Life Sciences Inc. and BioLineRx, Ltd.
Pre Book Full Report @ https://www.persistencemarketresearch.com/checkout/3102
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA,Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Kidney Fibrosis Treatment Market to Incur Rapid Extension During 2010-2020 here
News-ID: 883156 • Views: …
More Releases from Persistence Market Research
Fish Paste Market Size US$ 7.7 Bn in 2026 Driven by Rising Seafood Demand and Cu …
The global fish paste market is expected to register steady expansion over the forecast period, supported by rising demand for processed seafood products, evolving consumer dietary preferences, and the growing influence of traditional cuisines across international markets. The market is likely to be valued at US$ 7.7 billion in 2026 and is projected to reach approximately US$ 10.0 billion by 2033, expanding at a compound annual growth rate (CAGR) of…
Corn Germ Meal Market Value to Reach US$ 2.1 Bn by 2033 Driven by Rising Feed De …
The global corn germ meal market is anticipated to experience strong and sustained growth over the forecast period, driven by rising demand for cost-effective and nutritionally rich feed ingredients across livestock and aquaculture industries. The market is likely to be valued at approximately US$ 1.3 billion in 2026 and is projected to reach US$ 2.1 billion by 2033, expanding at a compound annual growth rate (CAGR) of 6.2% during the…
Butternut Squash Market Size US$3.3Bn to US$5.2Bn Driven by Healthy Diet Demand
The global butternut squash market is poised for strong and sustained expansion over the forecast period, driven by increasing consumer awareness of health and nutrition, growing demand for plant-based foods, and expanding applications across the food processing and foodservice industries. The market is likely to be valued at approximately US$ 3.3 billion in 2026 and is projected to reach US$ 5.2 billion by 2033, registering a compound annual growth rate…
U.S. Viscosupplementation Market to Reach US$1,611.7 Mn by 2032 | Persistence Ma …
The U.S. viscosupplementation market has emerged as a critical component of the broader orthopedic and musculoskeletal care ecosystem, driven primarily by the growing burden of osteoarthritis (OA) and the rising demand for minimally invasive pain management solutions. Viscosupplementation involves the intra-articular injection of hyaluronic acid (HA) to restore the viscoelastic properties of synovial fluid in osteoarthritic joints, thereby reducing pain, improving mobility, and delaying surgical intervention. As OA continues to…
More Releases for Fibrosis
Liver Fibrosis Pipeline: 50+ Companies Advancing Antifibrotic Therapies and Dise …
The therapeutic landscape for liver fibrosis, a pathological scarring process resulting from chronic liver injury, is rapidly evolving, as biopharmaceutical innovators shift their focus from symptomatic control to targeting the fibrogenic mechanisms driving disease progression. With no FDA-approved treatments specifically for reversing liver fibrosis, the spotlight is now on antifibrotic agents, inflammation modulators, and regenerative therapies aimed at halting or reversing fibrotic damage before it advances to liver fibrosis. Companies…
Kidney Fibrosis Treatment Market - Revitalize Your Kidneys: Innovative Therapies …
Newark, New Castle, USA: The "Kidney Fibrosis Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Kidney Fibrosis Treatment Market: https://www.growthplusreports.com/report/kidney-fibrosis-treatment-market/8877
This latest report researches the industry structure,…
Kidney Fibrosis Treatment Market - Leading the Way in Renal Fibrosis Management: …
Newark, New Castle, USA - new report, titled Kidney Fibrosis Treatment Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Kidney Fibrosis Treatment market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Kidney Fibrosis Treatment market. The report offers an overview of…
Cystic Fibrosis Market Report-Growth with Industry Study, Detailed Analysis | Cy …
The research study contains an in detail descriptive overview and analysis of the Cystic Fibrosis Market, a summary of the market shares constituted by each component, the annual growth of each sector, and the revenue potential of the section. In addition, Cystic Fibrosis Market production and consumption data are used to determine the geographical features.
Get FREE PDF sample of the Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=3639856
Top Company Profile Analysis in this Report-
Cystic Fibrosis…
The Cystic Fibrosis Market to Witness Robust Growth Due to Increasing Cases of C …
Cystic fibrosis is a rare, progressive, life-threatening disease results in the formation of thick mucus that builds up in the lungs, digestive tract, and other parts of the body. If left untreated, it leads to severe digestive and respiratory problems as well as other complications such as infections and diabetes. According to the Cystic Fibrosis Foundation, more than 70,000 people are living with cystic fibrosis around the world. As the…
Fibrosis - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Fibrosis - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fibrosis – Pipeline Review, H1 2017, provides an overview of the Fibrosis (Musculoskeletal Disorders) pipeline landscape.
Fibrosis is the excessive formation of fibrous bands of scar tissue in between muscle fibers. Fibrous scar tissue develops after the…
